Edwards Lifesciences Corporation Reclassification from AOCI, Current Period, before Tax, Attributable to Parent
Edwards Lifesciences Corporation (EW) reported Reclassification from AOCI, Current Period, before Tax, Attributable to Parent of $28.90 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent · last filed 2025-05-06
- Edwards Lifesciences Corporation reclassification from aoci, current period, before tax, attributable to parent for the quarter ending 2025-03-31 was $28.90M, a 351.56% increase year-over-year.
- Edwards Lifesciences Corporation reclassification from aoci, current period, before tax, attributable to parent for the quarter ending 2024-09-30 was $19.40M, a 32.88% increase year-over-year.
- Edwards Lifesciences Corporation reclassification from aoci, current period, before tax, attributable to parent for the quarter ending 2024-06-30 was $13.30M, a 42.67% decline year-over-year.
- Edwards Lifesciences Corporation reclassification from aoci, current period, before tax, attributable to parent for the quarter ending 2024-03-31 was $6.40M, a 76.73% decline year-over-year.
- Edwards Lifesciences Corporation reclassification from aoci, current period, before tax, attributable to parent for fiscal 2019 was $49.70M.
- Edwards Lifesciences Corporation reclassification from aoci, current period, before tax, attributable to parent for fiscal 2018 was -$15.30M, a 280.00% decline from fiscal 2017.
- Edwards Lifesciences Corporation reclassification from aoci, current period, before tax, attributable to parent for fiscal 2017 was $8.50M.
| Period end | Reclassification from AOCI, Current Period, before Tax, Attributable to Parent 3 month | Reclassification from AOCI, Current Period, before Tax, Attributable to Parent 6 month | Reclassification from AOCI, Current Period, before Tax, Attributable to Parent 9 month | Reclassification from AOCI, Current Period, before Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2025-03-31 | $28.90M 10-Q · filed 2025-05-06 | |||
| 2024-09-30 | $19.40M 10-Q · filed 2024-11-06 | $32.70M derived: sum of 2 quarters · filed 2024-11-06 | $39.10M derived: sum of 3 quarters · filed 2025-05-06 | |
| 2024-06-30 | $13.30M 10-Q · filed 2024-11-06 | $19.70M derived: sum of 2 quarters · filed 2025-05-06 | ||
| 2024-03-31 | $6.40M 10-Q · filed 2025-05-06 | |||
| 2023-09-30 | $14.60M 10-Q · filed 2024-11-06 | $37.80M derived: sum of 2 quarters · filed 2024-11-06 | $65.30M derived: sum of 3 quarters · filed 2024-11-06 | |
| 2023-06-30 | $23.20M 10-Q · filed 2024-11-06 | $50.70M derived: sum of 2 quarters · filed 2024-11-06 | ||
| 2023-03-31 | $27.50M 10-Q · filed 2024-11-06 | |||
| 2022-09-30 | $28.70M 10-Q · filed 2023-10-27 | $41.90M derived: sum of 2 quarters · filed 2023-10-27 | $46.00M derived: sum of 3 quarters · filed 2023-10-27 | |
| 2022-06-30 | $13.20M 10-Q · filed 2023-10-27 | $17.30M derived: sum of 2 quarters · filed 2023-10-27 | ||
| 2022-03-31 | $4.10M 10-Q · filed 2023-10-27 | |||
| 2021-09-30 | -$10.60M 10-Q · filed 2022-10-28 | -$17.40M derived: sum of 2 quarters · filed 2022-10-28 | -$15.80M derived: sum of 3 quarters · filed 2022-10-28 | |
| 2021-06-30 | -$6.80M 10-Q · filed 2022-10-28 | -$5.20M derived: sum of 2 quarters · filed 2022-10-28 | ||
| 2021-03-31 | $1.60M 10-Q · filed 2022-10-28 | |||
| 2020-09-30 | $7.00M 10-Q · filed 2021-10-29 | $15.60M derived: sum of 2 quarters · filed 2021-10-29 | $26.00M derived: sum of 3 quarters · filed 2021-10-29 | |
| 2020-06-30 | $8.60M 10-Q · filed 2021-10-29 | $19.00M derived: sum of 2 quarters · filed 2021-10-29 | ||
| 2020-03-31 | $10.40M 10-Q · filed 2021-10-29 | |||
| 2019-12-31 | $49.70M 10-K · filed 2020-02-14 | |||
| 2019-09-30 | $17.20M 10-Q · filed 2020-10-26 | $27.10M derived: sum of 2 quarters · filed 2020-10-26 | $35.70M derived: sum of 3 quarters · filed 2020-10-26 | |
| 2019-06-30 | $9.90M 10-Q · filed 2020-10-26 | $18.50M derived: sum of 2 quarters · filed 2020-10-26 | ||
| 2019-03-31 | $8.60M 10-Q · filed 2020-10-26 | |||
| 2018-12-31 | -$15.30M 10-K · filed 2020-02-14 | |||
| 2017-12-31 | $8.50M 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |